MicroRNA: Defining a new niche in Leukemia

Blood Rev. 2017 May;31(3):129-138. doi: 10.1016/j.blre.2016.11.003. Epub 2016 Nov 24.

Abstract

MicroRNAs (miRNAs) are endogenous short non-coding RNAs found to play key roles in the pathogenesis of leukemia. Apart from being traditionally identified as modulators of oncogenes, the potential roles of miRNAs seems to be growing with novel and recent findings among different subtypes of hematological malignancies. Leukemia is one of the earliest malignancies to be linked to abnormal expression of miRNAs. However, a clear understanding of the involvement of miRNAs in intricate mechanisms of leukemogenesis is still a necessity. This review summarizes the multiple roles of miRNAs in the pathogenesis of leukemia and highlights major research findings contributing to these aspects.

Keywords: Biomarkers; Leukemia; MicroRNAs.

Publication types

  • Review

MeSH terms

  • Animals
  • Biomarkers
  • Gene Expression Regulation, Leukemic*
  • Genetic Therapy / methods
  • Hematopoiesis / genetics
  • Humans
  • Leukemia / genetics*
  • Leukemia / metabolism
  • Leukemia / mortality
  • Leukemia / therapy
  • MicroRNAs / genetics*
  • Prognosis
  • RNA Interference*
  • Signal Transduction

Substances

  • Biomarkers
  • MicroRNAs